Tang Capital
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A PRECISION BIOSCIENCES Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Journey Medical Corp Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Evolus, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
-
Form SCHEDULE 13D HilleVax, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Spyre Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Acelyrin (SLRN) Reiterates Benefits of Value-Maximizing Combination with Alumis (ALMS)
-
Form SCHEDULE 13D/A Allakos Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Kiniksa Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A Allakos Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Acelyrin (SLRN) Adopts Limited-Duration Stockholder Rights Plan
-
Form SCHEDULE 13D/A ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D PLIANT THERAPEUTICS, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D/A ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D CARGO Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Acelyrin (SLRN) Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
-
Form SCHEDULE 13D ACELYRIN, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13D GALAPAGOS NV Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SCHEDULE 13G/A MARINUS PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SCHEDULE 13D Allakos Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Nkarta, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G CYBIN INC. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G Journey Medical Corp Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G LianBio Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G/A PRECISION BIOSCIENCES Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G/A KalVista Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
-
Form SC 13G/A BioAtla, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Quince Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC

